DENND5A expression based on
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison | Statistical significance |
Normal-vs-Primary | 3.95000032682447E-10 |
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
3.77939999995913E-06 |
Normal-vs-Stage2 |
1.239980E-03 |
Normal-vs-Stage3 |
N/A |
Normal-vs-Stage4 |
8.120600E-03 |
Stage1-vs-Stage2 |
4.105000E-01 |
Stage1-vs-Stage3 |
N/A |
Stage1-vs-Stage4 |
3.333400E-01 |
Stage2-vs-Stage3 |
N/A |
Stage2-vs-Stage4 |
7.875800E-01 |
Stage3-vs-Stage4 |
N/A |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
6.86129997262697E-09 |
Normal-vs-AfricanAmerican |
2.833200E-01 |
Normal-vs-Asian |
5.6208999998919E-07 |
Caucasian-vs-AfricanAmerican |
2.648100E-02 |
Caucasian-vs-Asian |
3.625800E-01 |
AfricanAmerican-vs-Asian |
5.673400E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
1.419470E-04 |
Normal-vs-Female |
3.26570000042103E-07 |
Male-vs-Female |
6.493200E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient BMI information is not available for 1 sample.
Descriptions |
Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Normal_Weight |
3.038400E-03 |
Normal-vs-Extreme_Weight |
7.66690000000292E-05 |
Normal-vs-Obese |
4.100500E-03 |
Normal-vs-Extreme_Obese |
N/A |
Normal_Weight-vs-Extreme_Weight |
5.559600E-01 |
Normal_Weight-vs-Obese |
2.105200E-01 |
Normal_Weight-vs-Extreme_Obese |
N/A |
Extreme_Weight-vs-Obese |
3.959400E-01 |
Extreme_Weight-vs-Extreme_Obese |
N/A |
Obese-vs-Extreme_Obese |
N/A |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
4.86310000047396E-07 |
Normal-vs-Age(41-60Yrs) |
9.201800E-04 |
Normal-vs-Age(61-80Yrs) |
1.65330000023722E-07 |
Normal-vs-Age(81-100Yrs) |
4.675200E-01 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.261000E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.318400E-02 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.041000E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.409800E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.130800E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.652600E-01 |
|
|
CHOL : Cholangiocarcinoma
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
N/A |
Normal-vs-Grade 2 |
2.039200E-01 |
Normal-vs-Grade 3 |
4.904000E-02 |
Normal-vs-Grade 4 |
1.000000E+00 |
Grade 1-vs-Grade 2 |
N/A |
Grade 1-vs-Grade 3 |
N/A |
Grade 1-vs-Grade 4 |
N/A |
Grade 2-vs-Grade 3 |
3.044200E-01 |
Grade 2-vs-Grade 4 |
2.039200E-01 |
Grade 3-vs-Grade 4 |
4.904000E-02 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 5 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
2.96470004101934E-09 |
Normal-vs-N1 |
9.155300E-03 |
N0-vs-N1 |
6.467400E-01 |
|
|